Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Sipai Wangluo Raises "Tens of Millions" of Dollars for China Oncology Big Data

publication date: Jun 3, 2016
Sipai Wangluo, a two-year old Beijing oncology big data company, has raised "tens of millions" of dollars in a Series B fundraising, according to China media reports. Sipai Wangluo positions itself as a diagnostic support system and differentiates itself from other oncology big data efforts by stressing its doctor-centered design. The money was invested by Ping An Ventures and two Fidelity funds, Eight Roads Ventures (formerly Fidelity Growth Partners) and F-Prime Capital Partners (formerly Fidelity Biosciences). In January 2015, Sipai Wangluo raised $10 million in its Series A round from the same investors. More details....

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital